UOC
DICE

UBS O'Connor’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

UBS O'Connor’s Portfolio DICE Stock Details DICE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,075,000
Closed -$49.9M – 689
2023
Q2 		$49.9M Buy
+1,075,000
New +$37.2M 1.05% 16

UBS O'Connor's DICE Position: Q3 2023 in Review

UBS O'Connor sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 1,075,000 shares — an estimated $49.9M sold.

UBS O'Connor first reported a position in DICE in Q2 2023 and held it in 1 quarter. The position peaked at $49.9M in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

  • UBS O'Connor reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • UBS O'Connor sold 1,075,000 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $49.9M.
  • UBS O'Connor first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • UBS O'Connor's DICE Therapeutics, Inc. Common Stock position peaked at $49.9M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on UBS O'Connor's 13F filing for Q3 2023, filed 14 Nov 2023.